Pfizer (PFE) Assets (2009 - 2026)

Pfizer (PFE) has 18 years of Assets data on file, last reported at $208.0 billion in Q1 2026.

• Assets for Q1 2026 came in at $208.0 billion, changed 0.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $208.0 billion (changed 0.01% YoY), and the FY2025 annual result was $208.2 billion, down 2.45% from the prior year.
• Assets steadied at $208.0 billion in Q1 2026 per PFE's latest filing, from $208.2 billion in the prior quarter.
• Over five years, Assets peaked at $226.5 billion in Q4 2023 and troughed at $41.1 billion in Q4 2022.
• A 5-year average of $199.1 billion and a median of $208.2 billion in 2025 frame the typical range for Assets.
• The sharpest annual moves came in 2022 and 2023: Assets fell 11.22% in 2022, then surged 422.64% in 2023.
• A 5-year view of Assets shows it stood at $197.0 billion in 2022, then grew by 14.98% to $226.5 billion in 2023, then declined by 5.79% to $213.4 billion in 2024, then retreated by 2.45% to $208.2 billion in 2025, then slipped by 0.08% to $208.0 billion in 2026.
• Business Quant data shows PFE's Assets at $208.0 billion in Q1 2026, $208.2 billion in Q4 2025, and $209.0 billion in Q3 2025.